It can be argued that the development of methods for restoring the balance of proteins involved in the formation of cristae and CJs, such as MICOS, OPA1, and SAM50 in hyperthyroidism, represents a new direction in the treatment of hyperthyroidism and other metabolic disorders. The gene discussed is SAMM50; the disease is metabolic disease.